서울대학교 중앙도서관

S-Space 소개

My S-Space

로그인이 필요합니다.

Login

S-Space

Browse

Subject

Jump to a point in the index

Or type in a year

Sort by
In order
Results/Page
Authors/record

Showing results 1 to 16 of 16

Issue Date	Title / Author(s) / Citation	File	Altmetrics
2007-10	Palliative chemotherapy for pulmonary pleomorphic carcinoma Bae, Hyun-Mi; Min, Hye Sook; Lee, Se-Hoon; Kim, Dong-Wan; Chung, Doo Hyun; Lee, Jong-Seok; Kim, Young Whan; Heo, Dae Seog Lung Cancer, Vol.58 No.1, pp.112-115	DOI
2012-01	Mesenchymal Stem/Stromal Cells (MSCs): Role as Guardians of Inflammation Prockop, Darwin J.; Oh, Joo Youn Molecular Therapy, Vol.20 No.1, pp.14-20	DOI
2012-02	Evaluation of the Antitumor Effects and Mechanisms of PF00299804, a Pan-HER Inhibitor, Alone or in Combination with Chemotherapy or Targeted Agents in Gastric Cancer Nam, Hyun-Jin; Ching, Keith A.; Kan, Julie; Kim, Hwang-Phill; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Christensen, James G.; Oh, Do-Youn; Bang, Yung-Jue Molecular Cancer Therapeutics, Vol.11 No.2, pp.439-451	DOI
2012-03	Adverse pulmonary reactions associated with the use of monoclonal antibodies in cancer patients Kang, Hyo Jae; Park, Jong Sun; Kim, Dong-Wan; Lee, Jinwoo; Jeong, Yun Jeong; Choi, Sun Mi; Lee, Sang-Min; Yang, Seok-Chul; Yoo, Chul-Gyu; Kim, Young Whan; Han, Sung Koo; Yim, Jae-Joon Respiratory Medicine, Vol.106 No.3, pp.443-450	DOI
2012-05	Medical therapies with adult stem/progenitor cells (MSCs): A backward journey from dramatic results in vivo to the cellular and molecular explanations Prockop, Darwin J.; Oh, Joo Youn Journal of Cellular Biochemistry, Vol.113 No.5, pp.1460-1469	DOI
2014-11	TSG-6 as a biomarker to predict efficacy of human mesenchymal stem/progenitor cells (hMSCs) in modulating sterile inflammation in vivo Lee, Ryang Hwa; Yu, Ji Min; Foskett, Andrea M.; Peltier, Grant; Reneau, John C.; Bazhanov, Nikolay; Oh, Joo Youn; Prockop, Darwin J. Proceedings of the National Academy of Sciences of the United States of America, Vol.111 No.47, pp.16766-16771	DOI
2015-04	Thalidomide inhibits alternative activation of macrophages in vivo and in vitro: A potential mechanism of anti-asthmatic effect of thalidomide Lee, Hyun Seung; Kwon, Hyouk-Soo; Park, Da-Eun; Woo, Yeon Duk; Kim, Hye Young; Kim, Hang-Rae; Cho, Sang-Heon; Min, Kyung-Up; Kang, Hye-Ryun; Chang, Yoon-Seok PLoS ONE, Vol.10 No.4, p. e0123094	DOI
2017-01	Clinical outcomes of stereotactic ablative radiotherapy in patients with pulmonary metastasis Jang, Bum-Sup; Kim, Hak Jae; Kim, Byoung Hyuck; Kim, Dong-Wan; Kim, Young Tae; Kim, Young Whan; Jang, Myoung-Jin; Wu, Hong-Gyun Japanese Journal of Clinical Oncology, Vol.47 No.1, pp.61-66	DOI
2017-05	MSC-derived Extracellular Vesicles Attenuate Immune Responses in Two Autoimmune Murine Models: Type 1 Diabetes and Uveoretinitis Shigemoto-Kuroda, Taeko; Oh, Joo Youn; Kim, Dong-ki; Jeong, Hyun Jeong; Park, Se Yeon; Lee, Hyun Ju; Park, Jong Woo; Kim, Tae Wan; An, Su Yeon; Prockop, Darwin J.; Lee, Ryang Hwa Stem Cell Reports, Vol.8 No.5, pp.1214-1225	DOI
2017-12	Ly6C(hi) monocytes are required for mesenchymal stem/stromal cell-induced immune tolerance in mice with experimental autoimmune uveitis Ko, Jung Hwa; Lee, Hyun Ju; Jeong, Hyun Jeong; Oh, Joo Youn Biochemical and Biophysical Research Communications, Vol.494 No.1-2, pp.6-12	DOI
2020-02	Overall Survival with Ribociclib plus Fulvestrant in Advanced Breast Cancer Slamon, Dennis J.; Neven, Patrick; Chia, Stephen; Fasching, Peter A.; De Laurentiis, Michelino; Im, Seock-Ah; Petrakova, Katarina; Bianchi, Giulia V.; Esteva, Francisco J.; Martin, Miguel; Nusch, Arnd; Sonke, Gabe S.; De la Cruz-Merino, Luis; Beck, J. Thaddeus; Pivot, Xavier; Sondhi, Manu; Wang, Yingbo; Chakravartty, Arunava; Rodriguez-Lorenc, Karen; Taran, Tetiana; Jerusalem, Guy New England Journal of Medicine, Vol.382 No.6, pp.514-524	DOI
2020-03	Mesenchymal Stem and Stromal Cells Harness Macrophage-Derived Amphiregulin to Maintain Tissue Homeostasis Ko, Jung Hwa; Kim, Hyeon Ji; Jeong, Hyun Jeong; Lee, Hyun Ju; Oh, Joo Youn Cell Reports, Vol.30 No.11, pp.3806-3820.e6	DOI
2021-10	Soluble PD-L1 is a predictive and prognostic biomarker in advanced cancer patients who receive immune checkpoint blockade treatment Oh, So Yeon; Kim, Soyeon; Keam, Bhumsuk; Kim, Tae Min; Kim, Dong-Wan; Heo, Dae Seog Scientific Reports, Vol.11 No.1, p. 19712
2021-12	Brigatinib Versus Crizotinib in ALK Inhibitor-Naive Advanced ALK-Positive NSCLC: Final Results of Phase 3 ALTA-1L Trial Camidge, D. Ross; Kim, Hye Ryun; Ahn, Myung-Ju; Yang, James C. H.; Han, Ji-Youn; Hochmair, Maximilian J.; Lee, Ki Hyeong; Delmonte, Angelo; Campelo, D. h Maria Rosario Garcia; Kim, Dong-Wan; Griesinger, Frank; Felip, Enriqueta; Califano, Raffaele; Spira, Alexander I.; Gettinger, Scott N.; Tiseo, Marcello; Lin, Huamao M.; Liu, Yuyin; Vranceanu, Florin; Niu, Huifeng; Zhang, Pingkuan; Popat, Sanjay Journal of Thoracic Oncology, Vol.16 No.12, pp.2091-2108	DOI
2023-07	Novel scoring system guiding the incorporation of adjuvant RT for neuroendocrine neoplasms treated with surgical resection followed by chemotherapy Kwon, Jeanny; Kim, Byoung Hyuck Journal of Cancer Research and Clinical Oncology, Vol.149 No.8, pp.4419-4428	DOI
2023-09	Clinical outcomes of radical radiotherapy for pulmonary sarcomatoid carcinoma Lee, Choong-Won; Kim, Byoung Hyuck; Kim, Hak Jae Radiation Oncology Journal, Vol.41 No.3, pp.163-171	DOI

1